Ingevity Q3 Earnings Call Highlights

Ingevity (NGVT) reports Q3 earnings, highlighting growth in hybrid vehicle and filtration markets. CEO Dave Li notes benefits from the hybrid transition and new water treatment contracts. Pavement Technologies sales fell 24% due to divestiture and higher asphalt costs. Advanced Polymer Technologies sales rose 18%. The company narrowed its 2026 adjusted EBITDA outlook to $385M-$395M and expects $1.1B in sales. Ingevity repurchased $39M in shares during Q3.

Original reporting
Published Nov 8, 2026, 8:14 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 8, 2026, 8:33 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Ingevity Q3 Earnings Call Highlights — source image
Decision brief

The 30-second read

$NGVTNeutralHigh
01

Why it matters

The earnings release provides fresh guidance and a sizable share repurchase, offering a clear catalyst for short‑term trading decisions.

02

Market read

First report of Q3 earnings and buyback details; relevant for traders tracking specialty chemicals and hybrid‑vehicle supply chain.

03

What to watch

Rising asphalt costs could pressure the pavement business, potentially dragging earnings.

Relevance 8/10Novelty 8/10Timing: post‑earnings today

Background

Ingevity (NYSE:NGVT) discussed Q3 results, hybrid vehicle demand, filtration contracts, and a narrowed buyback timeline.

Company-level read

Ticker impact

$NGVTNeutralHigh confidence
Context

Q3 earnings release with adjusted EBITDA outlook $385‑$395M and $1.1B sales guidance, plus $39M share repurchase disclosed.

Expected impact

likely modest upside as buyback support offsets flat guidance

Evidence & confidence

Guidance unchanged suggests no surprise, but the $39M repurchase may attract short‑term buying pressure.

Market effects

Hybrid‑vehicle shift and PFAS water‑treatment contracts may benefit the specialty chemicals sector.

North American hybrid vehicle demand could boost related suppliers.

Limited to specialty chemicals and automotive supply chain.

Counterpoint

Flat guidance may signal underlying demand weakness; investors could short on margin.

Key entities

  • Ingevity Corporation

    Specialty chemicals firm reporting Q3 earnings.

  • Dave Li

    CEO and President providing guidance.

Related articles

$NGVTMed

Ingevity (NGVT) Lifted EPS Guidance, Is The Stock Still Cheap?

Ingevity (NGVT) raised its full-year EPS guidance despite lower Q3 sales. The stock has fallen 15.34% in the past week but remains up 25.15% over one year. Analysts estimate fair value at $89, suggesting a 30% undervaluation, though its P/E ratio is higher than industry averages. The company plans $300M in share buybacks by 2027.

$NGVTMed

Ingevity (NGVT) Q3 2026 Earnings Call Transcript

Ingevity (NGVT) reported Q3 2026 sales of $305M, down 8% YoY due to divestitures, but up 2% excluding them. Adjusted EBITDA was $108M, down 2%, with margins expanding to 35.4%. EPS rose 24% to $1.63. The company highlighted growth in filtration and water treatment, secured new contracts, and repurchased $39M in shares. Full-year adjusted EBITDA is expected to be $385M-$395M, with sales around $1.1B and EPS of $5.25-$5.45.

$NGVTMed

Ingevity reports third quarter 2026 financial results

Ingevity Corp (NGVT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Ingevity Corporation 4920 O'Hear Avenue Suite 400 North Charleston, SC 29405 USA www.ingevity.com Ingevity reports third quarter 2026 financial results Third Quarter 2026 Results and Recent Highlights: • Net sales of $305.1 million decreased 8% from prior year; exclu

$NGVTHigh

Ingevity reports third quarter 2026 financial results

Ingevity reported Q3 2026 net sales of $305.1M, down 8% YoY. Net income rose to $51.1M per diluted share. Adjusted EBITDA fell $108M but margin expanded to 35.4%. The company narrowed its full-year adjusted EBITDA outlook to $385M-$395M. CEO Dave Li cited strong Performance Materials but noted challenges in Pavement Technologies. Ingevity (NYSE: NGVT) plans to host an earnings call on November 5, 2026.